| 64 |
Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer’s-like pathology and symptoms through multiple targeting actions in aged T2D rats |
Department of Pharmacology |
2023 |
| 65 |
Punicalagin’s protective effects on Parkinson’s progression in socially isolated and socialized rats: insights into multifaceted pathway |
Department of Pharmacology |
2023 |
| 66 |
The role of intestinal ultrasound with colour Doppler in predicting the response to biologic therapy in inflammatory bowel disease patients |
Department of Diagnostic Radiology |
2023 |
| 67 |
Interstitial Cystitis/Bladder Pain Syndrome: Role of Bladder Inflammation in Bladder Function |
Department of Urology |
2023 |
| 68 |
Overview of endocrine hypertension in children |
Department of Pediatrics |
2023 |
| 69 |
Prognostic value of echocardiographic indices in risk stratification of intermediate‑risk pulmonary embolism |
Department of Chest Diseases |
2023 |
| 70 |
Twelve-month outcomes of single-step transepithelial photorefractive keratectomy for moderate hyperopia and hyperopic astigmatism |
Department of Ophthalmology |
2023 |
| 71 |
Topiramate affords neuroprotection in diabetic neuropathy model via downregulating spinal GFAP/inflammatory burden and improving neurofilament production |
Department of Pharmacology |
2023 |
| 72 |
Quercetin Alleviated Inflammasome-Mediated Pyroptosis and Modulated the mTOR/P70S6/P6/eIF4E/4EBP1 Pathway in Ischemic Stroke |
Department of Pharmacology |
2023 |
